Zum Hauptinhalt springen

Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies.

Harris, WS ; Tintle, NL ; et al.
In: Nature communications, Jg. 12 (2021-04-22), Heft 1, S. 2329
Online academicJournal

Titel:
Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies.
Autor/in / Beteiligte Person: Harris, WS ; Tintle, NL ; Imamura, F ; Qian, F ; Korat, AVA ; Marklund, M ; Djoussé, L ; Bassett, JK ; Carmichael, PH ; Chen, YY ; Hirakawa, Y ; Küpers, LK ; Laguzzi, F ; Lankinen, M ; Murphy, RA ; Samieri, C ; Senn, MK ; Shi, P ; Virtanen, JK ; Brouwer, IA ; Chien, KL ; Eiriksdottir, G ; Forouhi, NG ; Geleijnse, JM ; Giles, GG ; Gudnason, V ; Helmer, C ; Hodge, A ; Jackson, R ; Khaw, KT ; Laakso, M ; Lai, H ; Laurin, D ; Leander, K ; Lindsay, J ; Micha, R ; Mursu, J ; Ninomiya, T ; Post, W ; Psaty, BM ; Risérus, U ; Robinson, JG ; Shadyab, AH ; Snetselaar, L ; Sala-Vila, A ; Sun, Y ; Steffen, LM ; Tsai, MY ; Wareham, NJ ; Wood, AC ; Wu, JHY ; Hu, F ; Sun, Q ; Siscovick, DS ; Lemaitre, RN ; Mozaffarian, D
Link:
Zeitschrift: Nature communications, Jg. 12 (2021-04-22), Heft 1, S. 2329
Veröffentlichung: [London] : Nature Pub. Group, 2021
Medientyp: academicJournal
ISSN: 2041-1723 (electronic)
DOI: 10.1038/s41467-021-22370-2
Schlagwort:
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Protective Factors
  • Risk Factors
  • Cause of Death
  • Fatty Acids, Omega-3 blood
  • Mortality, Premature
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Corporate Authors: Fatty Acids and Outcomes Research Consortium (FORCE)
  • Publication Type: Journal Article; Meta-Analysis
  • Language: English
  • [Nat Commun] 2021 Apr 22; Vol. 12 (1), pp. 2329. <i>Date of Electronic Publication: </i>2021 Apr 22.
  • MeSH Terms: Cause of Death* ; Mortality, Premature* ; Fatty Acids, Omega-3 / *blood ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prospective Studies ; Protective Factors ; Risk Factors
  • References: Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S. & Vane, J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2, 117–119 (1978). ; Bang, H. O. & Dyerberg, J. Lipid metabolism and ischemic heart disease in greenland eskimos. Adv. Nutr. Res. 3, 1–22 (1980). ; Hu, Y., Hu, F. B. & Manson, J. E. Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. J. Am. Heart Assoc. 8, e013543 (2019). (PMID: 31567003680602810.1161/JAHA.119.013543) ; Del Gobbo, L. C. et al. Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA Intern. Med. 176, 1155–1166 (2016). (PMID: 27357102518353510.1001/jamainternmed.2016.2925) ; Wan, Y., Zheng, J., Wang, F. & Li, D. Fish, long chain omega-3 polyunsaturated fatty acids consumption, and risk of all-cause mortality: a systematic review and dose-response meta-analysis from 23 independent prospective cohort studies. Asia Pac. J. Clin. Nutr. 26, 939–956 (2017). (PMID: 28802305) ; Wang, D. D. et al. Association of specific dietary fats with total and cause-specific mortality. JAMA Intern. Med. 176, 1134–1145 (2016). (PMID: 27379574512377210.1001/jamainternmed.2016.2417) ; Jackson, K. H., Polreis, J. M., Tintle, N. L., Kris-Etherton, P. M. & Harris, W. S. Association of reported fish intake and supplementation status with the omega-3 index. Prostaglandins Leukotrienes Essent. Fat. Aacids 142, 4–10 (2019). (PMID: 10.1016/j.plefa.2019.01.002) ; Barcelo-Coblijn, G. & Murphy, E. J. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog. Lipid Res. 48, 355–374 (2009). (PMID: 1961958310.1016/j.plipres.2009.07.002) ; Harris, W. S. et al. Red blood cell polyunsaturated fatty acids and mortality in the Women’s Health Initiative Memory Study. J. Clin. Lipidol. 11, 250–259 (2017). (PMID: 28391893556338210.1016/j.jacl.2016.12.013) ; Harris, W. S., Tintle, N. L., Etherton, M. R. & Vasan, R. S. Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: the Framingham Heart Study. J. Clin. Lipidol. 12, 718–724 (2018). (PMID: 29559306603462910.1016/j.jacl.2018.02.010) ; Mozaffarian, D. et al. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann. Intern. Med. 158, 515–525 (2013). (PMID: 23546563369884410.7326/0003-4819-158-7-201304020-00003) ; Iggman, D., Arnlov, J., Cederholm, T. & Riserus, U. Association of adipose tissue fatty acids with cardiovascular and all-cause mortality in elderly men. JAMA Cardiol. 1, 745–753 (2016). (PMID: 2754168110.1001/jamacardio.2016.2259) ; Chien, K. L. et al. Comparison of predictive performance of various fatty acids for the risk of cardiovascular disease events and all-cause deaths in a community-based cohort. Atherosclerosis 230, 140–147 (2013). (PMID: 2395826610.1016/j.atherosclerosis.2013.06.015) ; Lai, H. T. et al. Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study. Br. Med. J. 363, k4067 (2018). (PMID: 10.1136/bmj.k4067) ; FORCE. Fatty Acids and Outcomes Research Consortium. http://force.nutrition.tufts.edu/ (2020). ; Miura, K., Hughes, M. C. B., Ungerer, J. P. & Green, A. C. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study. Nutr. Res. 36, 1202–1209 (2016). (PMID: 2786561410.1016/j.nutres.2016.09.006) ; Lindberg, M., Saltvedt, I., Sletvold, O. & Bjerve, K. S. Long-chain n-3 fatty acids and mortality in elderly patients. Am. J. Clin. Nutr. 88, 722–729 (2008). (PMID: 1877928910.1093/ajcn/88.3.722) ; Kleber, M. E., Delgado, G. E., Lorkowski, S., Marz, W. & von Schacky, C. Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 252, 175–181 (2016). (PMID: 2739773410.1016/j.atherosclerosis.2016.06.049) ; Chen, G. C., Yang, J., Eggersdorfer, M., Zhang, W. & Qin, L. Q. N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis. Sci. Rep. 6, 28165 (2016). (PMID: 27306836491013210.1038/srep28165) ; Matsuda, H. et al. Evaluation of a high serum docosahexaenoic acid level as a predictor of longevity among elderly residents at a special nursing home. Geriatr. Gerontol. Int. 18, 980–982 (2018). (PMID: 2992449310.1111/ggi.13297) ; Wang, Y. et al. Fish consumption, blood docosahexaenoic acid and chronic diseases in Chinese rural populations. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 136, 127–140 (2003). (PMID: 1452763510.1016/S1095-6433(03)00016-3) ; Otsuka, R. et al. Fish and meat intake, serum eicosapentaenoic acid and docosahexaenoic acid levels, and mortality in community-dwelling Japanese Older Persons. Int. J. Environ. Res. Public Health 16, 1806 (2019). (PMID: 657251810.3390/ijerph16101806) ; Virtanen, J. K. et al. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler. Thromb. Vasc. Biol. 25, 228–233 (2005). (PMID: 1553962510.1161/01.ATV.0000150040.20950.61) ; Pottala, J. V., Garg, S., Cohen, B. E., Whooley, M. A. & Harris, W. S. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul Study. Circ. Cardiovasc. Qual. Outcomes 3, 406–412 (2010). (PMID: 20551373305860110.1161/CIRCOUTCOMES.109.896159) ; Zhang, Y. et al. Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421 309 individuals. J. Intern. Med. 284, 399–417 (2018). (PMID: 3001939910.1111/joim.12786) ; Bell, G. A. et al. Intake of long-chain omega-3 fatty acids from diet and supplements in relation to mortality. Am. J. Epidemiol. 179, 710–720 (2014). (PMID: 24496442393984910.1093/aje/kwt326) ; Li, Z.-H. et al. Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study. Br. Med. J. 368, m456 (2020). (PMID: 10.1136/bmj.m456) ; Pan, A. et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am. J. Clin. Nutr. 96, 1262–1273 (2012). (PMID: 23076616349792310.3945/ajcn.112.044040) ; Darwesh, A. M., Sosnowski, D. K., Lee, T. Y., Keshavarz-Bahaghighat, H. & Seubert, J. M. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system. Chemistry 308, 20–44 (2019). ; Wu, J. H. Y., Micha, R. & Mozaffarian, D. Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes. Nat. Rev. Cardiol. 16, 581–601 (2019). (PMID: 3109779110.1038/s41569-019-0206-1) ; Endo, J. & Arita, M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J. Cardiol. 67, 22–27 (2016). (PMID: 2635971210.1016/j.jjcc.2015.08.002) ; Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W. & Chiang, N. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 1851, 397–413 (2015). (PMID: 2513956210.1016/j.bbalip.2014.08.006) ; Farzaneh-Far, R., Harris, W. S., Garg, S., Na, B. & Whooley, M. A. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis 205, 538–543 (2009). (PMID: 1918529910.1016/j.atherosclerosis.2008.12.013) ; Chen, Z. et al. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression. Oncogene 33, 4548–4557 (2014). (PMID: 2409648210.1038/onc.2013.402) ; Liu, R. et al. High ratio of ω-3/ω-6 polyunsaturated fatty acids targets mTORC1 to prevent high-fat diet-induced metabolic syndrome and mitochondrial dysfunction in mice. J. Nutr. Biochem. 79, 108330 (2020). (PMID: 3217940810.1016/j.jnutbio.2019.108330) ; Nie, J. et al. Inhibition of mammalian target of rapamycin complex 1 signaling by n-3 polyunsaturated fatty acids promotes locomotor recovery after spinal cord injury. Mol. Med. Rep. 17, 5894–5902 (2018). (PMID: 294366955866035) ; Deyama, S. et al. Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway. Int. J. Neuropsychopharmacol. 20, 575–584 (2017). (PMID: 28419244549278010.1093/ijnp/pyx023) ; Papadopoli, D. et al. mTOR as a central regulator of lifespan and aging. F1000Res 8, 998 (2019). (PMID: 10.12688/f1000research.17196.1) ; Bjedov, I. & Rallis, C. The target of rapamycin signalling pathway in ageing and lifespan regulation. Genes 11, 1043 (2020). (PMID: 756555410.3390/genes11091043) ; Farzaneh-Far, R. et al. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. J. Am. Med. Assoc. 303, 250–257 (2010). (PMID: 10.1001/jama.2009.2008) ; Bernadotte, A., Mikhelson, V. M. & Spivak, I. M. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging 8, 3–11 (2016). (PMID: 26805432476170910.18632/aging.100871) ; Arbeev, K. G. et al. Association of leukocyte telomere length with mortality among adult participants in 3 longitudinal studies. JAMA Netw. Open 3, e200023 (2020). (PMID: 32101305713769010.1001/jamanetworkopen.2020.0023) ; Bernasconi, A. A., Wiest, M. M., Lavie, C. J., Milani, R. V. & Laukkanen, J. A. Effect of omega-3 dosage on cardiovascular outcomes: an updated meta-analysis and meta-regression of Interventional Trials. Mayo Clin. Proc. 96, 304–313 (2021). (PMID: 3295185510.1016/j.mayocp.2020.08.034) ; Nicholls, S. J. et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH Randomized Clinical Trial. J. Am. Med. Assoc. 324, 2268–2280 (2020). (PMID: 10.1001/jama.2020.22258) ; Zhang, Z. et al. Poultry and fish consumption in relation to total cancer mortality: a meta-analysis of prospective studies. Nutr. Cancer 70, 204–212 (2018). (PMID: 2927894010.1080/01635581.2018.1412474) ; Zhang, Y. F., Gao, H. F., Hou, A. J. & Zhou, Y. H. Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials. BMC Public Health 14, 204 (2014). (PMID: 24568238393802810.1186/1471-2458-14-204) ; Manson, J. E. et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N. Engl. J. Med. 380, 23–32 (2019). (PMID: 3041563710.1056/NEJMoa1811403) ; Richter, C. K. et al. n-3 Docosapentaenoic acid intake and relationship with plasma long-chain n-3 fatty acid concentrations in the United States: NHANES 2003-2014. Lipids 54, 221–230 (2019). (PMID: 31025717668181910.1002/lipd.12146) ; Drouin, G., Rioux, V. & Legrand, P. The n-3 docosapentaenoic acid (DPA): a new player in the n-3 long chain polyunsaturated fatty acid family. Biochimie 159, 36–48 (2019). (PMID: 3071635810.1016/j.biochi.2019.01.022) ; Meyer, B. J. & Groot, R. H. M. Effects of omega-3 long chain polyunsaturated fatty acid supplementation on cardiovascular mortality: the importance of the dose of DHA. Nutrients 9, 1305 (2017). (PMID: 574875510.3390/nu9121305) ; von Schacky, C. Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease. Evid. Based Med. 18, e33 (2013). (PMID: 10.1136/eb-2012-100960) ; Rice, H. B. et al. Conducting omega-3 clinical trials with cardiovascular outcomes: proceedings of a workshop held at ISSFAL 2014. Prostaglandins Leukotrienes Essent. Fat. Acids 107, 30–42 (2016). (PMID: 10.1016/j.plefa.2016.01.003) ; U.S. Department of Agriculture, A.R.S. Dietary Guidelines for Americans 2015–2020. https://www.dietaryguidelines.gov/current-dietary-guidelines/2015-2020-dietary-guidelines (2015). ; Bhatt, D. L. et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N. Engl. J. Med. 380, 11–22 (2019). (PMID: 3041562810.1056/NEJMoa1812792) ; Kalstad, A. A. et al. Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized controlled trial. Circulation 143, 528–539 (2021). (PMID: 3319177210.1161/CIRCULATIONAHA.120.052209) ; Harris, W. S., Pottala, J. V., Vasan, R. S., Larson, M. G. & Robins, S. J. Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans. J. Nutr. 142, 1297–1303 (2012). (PMID: 22623386337466810.3945/jn.112.158295) ; Flock, M. R. et al. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J. Am. Heart Assoc. 2, e000513 (2013). (PMID: 24252845388674410.1161/JAHA.113.000513) ; Young, A. J. et al. Blood fatty acid changes in healthy young Americans in response to a 10-week diet that increased n-3 and reduced n-6 fatty acid consumption: a randomised controlled trial. Br. J. Nutr. 117, 1257–1269 (2017). ; Arab, L. Biomarkers of fat and fatty acid intake. J. Nutr. 133, 925S–932S (2003). (PMID: 1261217810.1093/jn/133.3.925S) ; Hodson, L., Skeaff, C. M. & Fielding, B. A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47, 348–380 (2008). (PMID: 1843593410.1016/j.plipres.2008.03.003) ; Siscovick, D. S. et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J. Am. Med. Assoc. 274, 1363–1367 (1995). (PMID: 10.1001/jama.1995.03530170043030) ; Albert, C. M. et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346, 1113–1118 (2002). (PMID: 1194827010.1056/NEJMoa012918) ; Harris, T. B. et al. Age, gene/environment susceptibility–Reykjavik study: multidisciplinary applied phenomics. Am. J. Epidemiol. 165, 1076–1087 (2007). (PMID: 17351290272394810.1093/aje/kwk115) ; Orsini, N., Li, R., Wolk, A., Khudyakov, P. & Spiegelman, D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am. J. Epidemiol. 175, 66–73 (2011). (PMID: 22135359324460810.1093/aje/kwr265) ; Viechtbauer, W. Conducting meta-analyses in R with the metafor Package. J. Stat. Softw. 36, 48 (2010). (PMID: 10.18637/jss.v036.i03) ; Team, R. C. R.: a language and environment for statistical computing. https://www.R-project.org/ (2019).
  • Grant Information: MC_UU_00006/1 United Kingdom MRC_ Medical Research Council; MC_UU_12015/1 United Kingdom MRC_ Medical Research Council; T32 CA009001 United States CA NCI NIH HHS; MC_UU_12015/5 United Kingdom MRC_ Medical Research Council; MC_UU_00006/3 United Kingdom MRC_ Medical Research Council
  • Substance Nomenclature: 0 (Fatty Acids, Omega-3)
  • Entry Date(s): Date Created: 20210423 Date Completed: 20210511 Latest Revision: 20230201
  • Update Code: 20240513
  • PubMed Central ID: PMC8062567

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -